PROTAC BRD4 Degrader-1
Code | Size | Price |
---|
TAR-T13833-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T13833-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
PROTAC BRD4 Degrader-1 is an efficacious degrader of BRD4(BRD4 BD1,IC50 of 41.8 nM).
CAS:
2133360-00-4
Formula:
C40H37N9O8
Molecular Weight:
771.78
Pathway:
Chromatin/Epigenetic
Purity:
0.98
SMILES:
O=C1C=2C=CC=C(NC(=O)COCCN3N=NC(=C3)CN4C(=O)N(C5=CC=C(C=C5C4C=6C=CC=CC6)C=7C(=NOC7C)C)C)C2C(=O)N1C8C(=O)NC(=O)CC8
Target:
Epigenetic Reader Domain
References
Zhang F, et al. Discovery of a new class of PROTAC BRD4 degraders based on a dihydroquinazolinone derivative and lenalidomide/pomalidomide.Bioorg Med Chem. 2020 Jan 1;28(1):115228.